Guidelines from the American Society of Clinical Oncology discourage the use of CA19-9 as a screening test for cancer, particularly pancreatic cancer.
Vodiči izdato od Američka udruga za kliničku onkologiju (American Society of Clinical Oncology) ne ohrabruju uporabu CA19-9 kao skrining testa za rak, osobito za rak gušterače.